LogicBio Therapeutics Inc.

NAS: LOGC

GO
/marketstate/country/us

Market open

 --Real time quotes

Mar 5, 2021, 9:30 a.m.

/zigman2/quotes/206745651/composite

$

7.75

Change

-0.09 -1.15%

Volume

Volume 13,032

Real time quotes

/zigman2/quotes/206745651/composite

Previous close

$ 7.84

$ 7.75

Change

-0.09 -1.15%

Day low

Day high

$7.74

$7.75

Open

52 week low

52 week high

$3.05

$10.00

Open

Annual Financials for LogicBio Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 2016201720182019 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A -16,00043,00089,000289,000
COGS excluding D&A -----
Depreciation & Amortization Expense -16,00043,00089,000289,000
Depreciation -16,00043,00089,000289,000
Amortization of Intangibles -----
Gross Income -(16,000)(43,000)(89,000)(289,000)
2016201720182019 5-year trend
SG&A Expense -3.39M5.81M17.85M40.75M
Research & Development -2.03M3.56M11.08M30.66M
Other SG&A -1.36M2.25M6.78M10.1M
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense -(7,000)67,000(159,000)(19,000)
Non-Operating Interest Income --54,000567,0001.5M
Equity in Affiliates (Pretax) -----
Interest Expense ----546,000
Gross Interest Expense ----546,000
Interest Capitalized -----
Pretax Income -(3.41M)(5.73M)(17.54M)(40.11M)
Income Tax -18,00062,00086,00022,000
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income -(3.43M)(5.8M)(17.62M)(40.13M)
Minority Interest Expense -----
Net Income -(3.43M)(5.8M)(17.62M)(40.13M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries -(3.43M)(5.8M)(17.62M)(40.13M)
Preferred Dividends -337,0001.94M--
Net Income Available to Common -(3.77M)(7.74M)(17.62M)(40.13M)
EPS (Basic) -(0.16)(0.34)(3.04)(1.78)
Basic Shares Outstanding -22.99M22.99M5.8M22.6M
EPS (Diluted) -(0.16)(0.34)(3.04)(1.78)
Diluted Shares Outstanding -22.99M22.99M5.8M22.6M
EBITDA -(3.39M)(5.81M)(17.85M)(40.75M)
Link to MarketWatch's Slice.